Glynn Capital Management’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$73.5M Sell
2,575,828
-15,964
-0.6% -$344K 20.22% 1
2026
Q1
$29.7M Sell
2,591,792
-148,805
-5% -$2.1M 14.21% 1
2025
Q4
$39.4M Sell
2,740,597
-115,428
-4% -$2M 13.53% 1
2025
Q3
$54.1M Sell
2,856,025
-153,753
-5% -$2.53M 17.06% 1
2025
Q2
$64.5M Sell
3,009,778
-105,439
-3% -$1.57M 14.51% 1
2025
Q1
$40.8M Buy
3,115,217
+381,980
+14% +$5.67M 10.74% 1
2024
Q4
$36.7M Buy
2,733,237
+817,518
+43% +$13.2M 8.66% 1
2024
Q3
$40.6M Hold
1,915,719
9.3% 2
2024
Q2
$30.3M Hold
1,915,719
6.12% 8
2024
Q1
$28.5M Hold
1,915,719
5.34% 9
2023
Q4
$17.5M Hold
1,915,719
3.28% 13
2023
Q3
$10.7M Hold
1,915,719
2.32% 16
2023
Q2
$15.4M Hold
1,915,719
3.43% 13
2023
Q1
$12.5M Hold
1,915,719
2.98% 15
2022
Q4
$4.71M Hold
1,915,719
1.14% 21
2022
Q3
$9.56M Hold
1,915,719
2.04% 19
2022
Q2
$8.14M Hold
1,915,719
1.69% 21
2022
Q1
$19.1M Hold
1,915,719
2.57% 17
2021
Q4
$15M Hold
1,915,719
1.6% 20
2021
Q3
$33.3M Buy
+1,915,719
New +$32.5M 2.92% 14

Other funds holding OSCR

Glynn Capital Management's OSCR Position: Q2 2026 in Review

Glynn Capital Management reduced its Oscar Health (OSCR) stake by 0.62% in Q2 2026, selling an estimated $344K and leaving 2,575,828 shares worth $73.5M. The position accounts for 20.22% of the portfolio, ranked #1.

Glynn Capital Management first reported a position in OSCR in Q3 2021 and has held it in 20 quarters since. 403 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Glynn Capital Management held 2,575,828 shares of Oscar Health worth $73.5M as of Q2 2026.
  • Glynn Capital Management sold 15,964 Oscar Health shares in Q2 2026, an estimated $344K.
  • Oscar Health made up 20.22% of Glynn Capital Management's portfolio in Q2 2026, its #1 holding.
  • Glynn Capital Management first reported a position in Oscar Health in Q3 2021 and has held it in 20 quarters since.
  • 403 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Glynn Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.